Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

BACKGROUND: Globally, hepatocellular carcinoma is the second most common cause of cancer deaths. It remains challenging to intensify cancer treatment without impairing liver function. OBJECTIVE: The objective of the TheraSphere in the Treatment of Patients with Unresectable Hepatocellular Carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Nikhil, Bukovcan, Janet, Boucher, Eveline, Cosgrove, David, Edeline, Julien, Hamilton, Bonnie, Kulik, Laura, Master, Fayaz, Salem, Riad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115595/
https://www.ncbi.nlm.nih.gov/pubmed/30111528
http://dx.doi.org/10.2196/11234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115595/
https://www.ncbi.nlm.nih.gov/pubmed/30111528
http://dx.doi.org/10.2196/11234

Ejemplares similares